The DLLR website will be unavailable from about 8:00 AM ET until about 12:00 PM ET on Saturday, October 4, 2014. We apologize for the inconvenience. Thank you for your patience.

About DLLR

 

09.10.03 - Racing Commission - Pending Regulations

 

PROPOSED ACTION ON REGULATIONS
MARYLAND REGISTER, VOLUME 41, ISSUE 14,
FRIDAY, JULY 11, 2014

Title 09 DEPARTMENT OF LABOR, LICENSING, AND REGULATION

Subtitle 10 RACING COMMISSION

09.10.03 Prohibited Acts

Authority: Business Regulation Article, §11-210, Annotated Code of Maryland

Notice of Proposed Action
[14-201-P]

The Maryland Racing Commission proposes to amend Regulation .01-1 under COMAR 09.10.03 Prohibited Acts. This action was considered by the Maryland Racing Commission at a public meeting held on May 20, 2014, notice of which was given by publication in 41:9 Md. R. 542 (May 2, 2014), in accordance with State Government Article, §10-506(c), Annotated Code of Maryland.

Statement of Purpose

The purpose of this action is to add two therapeutic medications to the current list of 24 permissive medications and to lower the permitted threshold of ketophen.

Comparison to Federal Standards

There is no corresponding federal standard to this proposed action.

Estimate of Economic Impact

The proposed action has no economic impact.

Economic Impact on Small Businesses

The proposed action has minimal or no economic impact on small businesses.

Impact on Individuals with Disabilities

The proposed action has no impact on individuals with disabilities.

Opportunity for Public Comment

Comments may be sent to J. Michael Hopkins, Executive Director, Maryland Racing Commission, 300 East Towsontown Blvd. Towson, MD 21286, or call 410-296-9682, or email to mike.hopkins@maryland.gov, or fax to 410-296-9687. Comments will be accepted through August 15, 2014. A public hearing has not been scheduled.

Open Meeting

Final action on the proposal will be considered by the Maryland Racing Commission during a public meeting to be held on August 19, 2014, at 12:30 p.m. at Ocean Downs Raceway, Berlin, Maryland.

.01-1 Restricted Use of Medications and Other Substances.
The use of the following medications and other substances are permitted if quantitated at not more than the specified thresholds:
  A. (text unchanged)
  A-1. Albuterol quantitated at not more than 1 nanogram per milliliter of urine;
  B.— N. (text unchanged)
  N-1. Isoflupredone quantitated at not more than 100 picograms per milliliter of blood plasma or serum;
  O. Ketoprofen quantitated at not more than [10] 2 nanograms per milliliter of blood plasma or serum;
  P. —Y. (text unchanged)
  [Z. Stanozolol quantitated at not more than 1 nanogram per milliliter of urine;]
  [AA.] Z. — [DD.] CC. (text unchanged)

J. MICHAEL HOPKINS
Executive Director